INOVIQ LTD — Director's Dealing 2020

Aug 23, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	BARD1 LIFE SCIENCES LIMITED (BD1)
ABN	58 009 070 384

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	DR GEOFFREY CUMMING
Date of last notice	4 August2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	IndirectJamelys Superannuation Fund
Date of change	17 August2020
No. of securities held prior to change	3,472,802*Nil#
Class	*Ordinary Fully Paid Shares#Unlisted Incentive Options
Number acquired/despatched	Nil*1,560,000#
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	BD1 Incentive Options issued perScheme ofArrangement between BD1 and Sienna CancerDiagnostics Limited (SDX), exchange of SDX options

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change
	3,472,802ordinary fully paid shares
	1,560,000 unlisted BD1 incentive options
Nature of change	BD1 incentive optionsacquiredper theScheme of
Example: on-market trade, off-market trade, exercise of options, issue	Arrangement
of securities under dividend reinvestment plan, participation in buy-
back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written	No
clearance was required?
If so, was prior written clearance provided to allow the
trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was	N/A
this provided?

Dated: 29/07/2019

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011